CAS 3064599-36-3

GSK4418959/IDE275

Formule : C₃₁H₃₀F₄N₄O₅S

Synonymes :

• IDE275
• (1R,2R,6S)-2-((2-Fluoro-4-(trifluoromethyl)phenyl)carbamoyl)-6-(4-((N,1,2-trimethyl-1H-benzo[d]imidazole)-5-sulfonamido)phenyl)cyclohexane-1-carboxylic acid
• (1R,2R,6S)-2-{[2-fluoro-4-(trifluoromethyl)phenyl]aminoformyl}-6-[4-(N-methyl-1,2-dimethyl-1H-1,3-benzodiazole-5-sulfonamido)phenyl]cyclohexane-1-carboxylic acid
• Cyclohexanecarboxylic acid, 2-[4-[[(1,2-dimethyl-1H-benzimidazol-5-yl)sulfonyl]methylamino]phenyl]-6-[[[2-fluoro-4-(trifluoromethyl)phenyl]amino]carbonyl]-, (1R,2S,6R)-
• GSK4418959/IDE275

GSK4418959

CAS : 3064599-36-3

GSK4418959

Formule : C₃₁H₃₀F₄N₄O₅S

Degré de pureté : ≥98%

Masse moléculaire : 646.65

Ref: 54-BUP22977

GSK4418959

CAS : 3064599-36-3

GSK4418959 (IDE275) is a selective WRN helicase inhibitor that blocks ATPase and DNA unwinding, serving as a tool in MSI-H cancer research.

Formule : C₃₁H₃₀F₄N₄O₅S

Degré de pureté : 99.14%

Couleur et forme : White Solid

Masse moléculaire : 646.65

Ref: TM-T204089